An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism

Human Immunology

Volumn 46, Issue 1, 1996, Pages 49-54

  Hawrami, Khidir ^a   Hitman, Graham A ^a   Rema, Mohan ^b   Snehalatha, Chamukuttan ^c   Viswanathan, Moopil ^c   Ramachandran, Ambady ^c   Mohan, Viswanathan ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b MV Diabetes Specialities Centre (P) Ltd 6B (Old No35)   (India)

^c Diabetes Research Centre Tamil Nadu   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3;

ADULT; ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029875920     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(95)00177-8     Document Type: Article

References (38)

1. Cahill FC, Etzweiler DD, Freinkel N: 'Control' and diabetes. N Engl J Med 294:1004, 1976.
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive insulin treatment of diabetes on the development and progression ot long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977, 1993.
3. Leslie RDG, Pyke DA: Diabetic retinopathy in identical twins. Diabetes 31:19, 1982.
4. Barnett AH, Spiliopoulous AJ, Pyke DA, Stubbs WA, Rowold E, Hoffmann P, Faller A, Kilo C, Miller JP, Williamson JR: Muscle capillary basement membrane thickness in identical twins discordant for insulin dependent diabetes. Diabetes 32:557, 1983.
5. Dornan TL, Ting A, McPherson CK, Peckar CO, Mann JI, Turner RC, Morris PJ: Genetic susceptibility to the development of retinopathy in insulin dependent diabetics. Diabetes 31:226, 1982.
6. Betrams J, Dewald G, Spitzans M, Rittner CH: HLA-A, B, C, DR, BF and C2 allele in insulin dependent diabetes with proliferative retinopathy. Immunobiology 158:113, 1980.
7. Malone JI, Grizzard WS, Espinoza LR, Achenbach KE, Van Cader TC: Risk factors for diabetic retinopathy in youth. Pediatrics 73:756, 1984.
8. Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T: Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 313: 1433, 1985.
9. Baker RS, Rand LI, Krolewski AS, Maki T, Warram JH, Aiello LM: Influence of HLA-DR phenotype and myopia on the risk of non-proliferative diabetic retinopathy. Am J Ophthal 102:693, 1986.
10. Mijovic C, Fletcher JA, Bradwell AR, Harvey T, Barnett AH: Relation of gene expression (allotype) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications. Br Med J 291:9, 1985.
11. Larkins RG, Martin FIR, Tait BD: HLA patterns and diabetic retinopathy. Br Med J 1:1111, 1978.
12. Stand E, Dexel T, Lander T, Albert Edm Scholz S: Antigens and diabetic retinopathy: a different view warranted. Diabetologia 18:79, 1980.
13. Barbosa J, Ramsay RC, Knobloch WH, Cantrill HL, Noreen H, King R, Yunis E: Histocompatibility antigen frequencies in diabetic retinopathy. Am J Ophthalmol 90: 148, 1980.
14. Jervell J, Solhiem B: HLA antigens in longstanding insulin-dependent diabetes with terminal nephropathy and retinopathy with and without loss of vision. Diabetologia 17:391, 1979.
15. Deckert T, Egeberg J, Frimodt-Moller C, Sander E, Svejgaad A: Basement membrane thickness, insulin antibodies and HLA-antigens in long-standing insulin-dependent diabetics with and without severe retinopathy. Diabetologia 17:91, 1979.
16. Cove DH, Walker JM, Wells L, Mackintosh P, Wright AD: Are HLA types of Bf allele markers for diabetic retinopathy? Diabetologia 19:402, 1980.
17. Barbosa J, Saner B: Do genetic factors play a role in pathogenesis of diabetic microangiopathy. Diabetologia 27: 487, 1984.
18. Cruickshanks KJ, Vadheim CM, Moss SE, Roth MP, Riley WJ, Maclaren NK, Langfield D, Sparkes RS, Klein R, Rotter JI: Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 years of age. Diabetes 41:879, 1992.
19. Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T: Linkage map of the human major histocompatibility complex including tumour necrosis factor genes. Proc Natl Acad Sci USA 84: 8535, 1987.
20. Pociot F, Briant L, Jongened CV, Molvig J, Abbul M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumour necrosis factor (TNF) and class 11 major histocompatibility complex alleles with the secretion of TNF-α and TNF-β human mononuclear cells: a possible link to insulin dependent diabetes mellitus. Eur J Immunol 23:224, 1993.
21. Jongeneel CV, Brian L, Udalova IA, Sevin A, Nedospasov SA, Thomsen AC: Extensive genetic polymorphism in the human tumour necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA 88: 9717, 1991.
22. Medcraft J, Hitman GA, Sachs JA, Whichelow CE, Raafat I, Moore RH: Autoimmune renal disease and tumor necrosis factor β gene polymorphism. Clin Nephrol 40:63, 1993.
23. Cox A, Gonzalez AM, Wilson AG, Wilson RM, Ward JB, Artlett CM, Welsh K, Duff GW: Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 37:500, 1994.
24. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL: DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus: numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellite in the upstream region of the lymphotoxin (TNF-β) gene. J Immunol 3:1053, 1991.
25. Klein R, Klein BE, Moss SE, David MD, DeMets DL: Wisconsin Epidemiologic Study of Diabetic Retinopathy: III: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527, 1984.
26. Diabetic Retinopathy Study Research Group: Report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21:210, 1981.
27. Balnaves ME, Nasioulas S, Dahl HHM, Forrest S: PCR from CVS and blood lysates for detection of cystic fibrosis and Duchenne muscular dystrophy deletions. Nucleic Acids Res 19:1155, 1991.
28. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA: Heritable major histocompatibility complex class II associated differences in production of tumour necrosis factor-α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233, 1990.
29. Held W, MacDonald HR, Weisman IL, Hess M, Mueller C: Genes encoding tumour necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 87:2239, 1990.
30. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, Goeddel DV, Gray PW: Human lymphotoxin and tumour necrosis factor genes: structure, homology and chromosomal localisation. Nucleic Acids Res 13:6361, 1985.
31. Paul NL, Ruddle NH: Lymphotoxin. Annu Rev Immunol 6:407, 1988.
32. Jacob CO, McDevitt HO: Tumour necrosis factor TNF-α in murine autoimmune 'lupus nephritis. Nature 331: 356, 1980.
33. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H: Prevention of diabetes in non-obese diabetic mice by tumour necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc Natl Acad Sci USA 87: 968, 1990.
34. Pujol-Borrel R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf GR, Feldmann M: HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 326:304, 1987.
35. Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Baek L, Nerup J: A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin dependent diabetes mellitus. Scand J Immunol 33: 37, 1991.
36. Kopolovic K, Berman A, Brownlee M, King GL: Characterization of tumour necrosis factors (TNF) inhibitory effect on proliferation and permeability function of retinal capillary endothelial cells. Diabetes 37:122A, 1988.
37. Ferro TJ, Parker DM, Commins LM, Philips PG, Johnson A: Tumour necrosis factor α-activates pulmonary artery endothelial protein kinase C. Am J Physiol 264:L7, 1993.
38. Hawrami K, Mohan R, Mohan V, Hitman GA: A genetic study of retinopathy in South Indian non-insulin dependent diabetics. Diabetologia 34:441, 1991.